Anthony J Bench - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Anthony J Bench

Showing results (21-30 of 25) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 25 results.

Blood|May 3, 2008

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohortPhilip A Beer, Peter J Campbell, Linda M Scott, et al.

British Journal of Haematology|January 28, 2009

Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clonesPhilip A Beer, Amy V Jones, Anthony J Bench, et al.

Blood|July 29, 2006

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformationPeter J Campbell, E Joanna Baxter, Philip A Beer, et al.

British Journal of Haematology|October 13, 2012

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutationsAnthony J Bench, Helen E White, Letizia Foroni, et al.

Lancet (London, England)|December 6, 2005

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective studyPeter J Campbell, Linda M Scott, Georgina Buck, et al.

Pageof 3

Search research articles

Showing results (21-30 of 25) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 25 results.

Blood|May 3, 2008

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohortPhilip A Beer, Peter J Campbell, Linda M Scott, et al.

British Journal of Haematology|January 28, 2009

Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clonesPhilip A Beer, Amy V Jones, Anthony J Bench, et al.

Blood|July 29, 2006

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformationPeter J Campbell, E Joanna Baxter, Philip A Beer, et al.

British Journal of Haematology|October 13, 2012

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutationsAnthony J Bench, Helen E White, Letizia Foroni, et al.

Lancet (London, England)|December 6, 2005

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective studyPeter J Campbell, Linda M Scott, Georgina Buck, et al.

Pageof 3